🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Around 75% of breast cancers are defined and driven by Oestrogen receptor a...
Status
Completed
Location
Cambridge University Hospitals NHS Foundation Trust
Start Date
2017-07-20
Trial ID
NCT03306472
Treatments Being Tested
This research study is evaluating a drug called Palbociclib in combination ...
Status
Completed
Location
University of California, San Francisco
Start Date
2014-01
Trial ID
NCT02040857
Treatments Being Tested
Patients with locally advanced (stage III) breast cancer (LABC) are charact...
Status
Completed
Location
Akershus University Hospital
Start Date
2022-12-01
Trial ID
NCT05163106
Treatments Being Tested
Randomized phase III multicenter study investigating the role of letrozole ...
Status
Terminated
Location
DH Tumori Femminili
Start Date
2020-06-22
Trial ID
NCT04421547
Treatments Being Tested
The present study is to determine the adverse effects and clinical efficacy...
Status
Unknown
Location
FUSCC
Start Date
2010-10
Trial ID
NCT01924078
Treatments Being Tested
Aim to investigate the effect of Letrozole as maintenance after adjuvant tr...
Status
Terminated
Location
Obstetrics and Gynecology Hospital of Fudan University
Start Date
2022-08-02
Trial ID
NCT05454358
Treatments Being Tested
Eligible patients with estrogen receptor positive breast cancer will underg...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-11-13
Trial ID
NCT03573648
Treatments Being Tested
This is a phase II study evaluating the efficacy and safety of the pre-oper...
Status
Unknown
Location
Unimed Medical Institute
Start Date
2012-02
Trial ID
NCT01709370
Treatments Being Tested
In order to get optimal pregnancy rates after frozen embryo transfer (FET),...
Status
Unknown
Location
Rahem fertility center
Start Date
2024-02-24
Trial ID
NCT06181305
Treatments Being Tested
This is an investigator-initiated randomized controlled, open-label, multic...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-12-20
Trial ID
NCT05638594